Please login to the form below

Not currently logged in
Email:
Password:

Chris Molloy is new head of RSA

Life sciences executive search and interim management specialist RSA has appointed a new chief executive

RSA Chris MolloyChris Molloy, a non-executive director at RSA since 2009, joins RSA in a full-time capacity from IDBS, where he was VP, corporate development and marketing.

Molloy brings with him more than 20 years' experience in life sciences, spanning the pharmaceuticals, biotechnology and start-up sectors.

He started out with Glaxo, where he held a range of management, research, business change and scientific collaboration roles through the company's merger to become GlaxoSmithKline (GSK), before moving to Asia in 2004 as chief operating officer of emerging biotech firm MerLion Pharmaceuticals.

In addition to taking over as CEO at RSA, Molloy will retain his active scientific role in the pre-clinical development and licensing of new medicines for HIV with KFLP Biotech, a 'virtual' US R&D company.

“We are excited to have Chris on board as RSA's CEO. He will continue to preserve the special culture and feel of RSA whilst making us even more professional as an executive search and interim business,” said executive chairman Nick Stephens.

11th September 2013

From: Sales, Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics